Clinical trial

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

NCT00004230

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-10-01

PhasePHASE3

Study timeline

Study start (unknown)1999-10-01Date precision: month

Registry last updated2012-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Interventions

captoprilDRUG · verified · RxNorm: captopril

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

autologous bone marrow transplantationPROCEDURE

peripheral blood stem cell transplantationPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Northwestern Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004230 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.